Jazz Pharmaceuticals JAZZ Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's interest paid?
- Jazz Pharmaceuticals (JAZZ) reported interest paid of $62.14M in Q4 2025.
- How has Jazz Pharmaceuticals's interest paid changed year-over-year?
- Jazz Pharmaceuticals's interest paid decreased by 21.0% year-over-year, from $78.71M to $62.14M.
- What is the long-term trend for Jazz Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's interest paid has grown at a 15.8% compound annual growth rate (CAGR), from $138.27M to $248.55M.
- What does interest paid mean?
- The actual cash amount paid to lenders for interest.
- How do you interpret interest paid?
- An increase suggests higher debt levels or rising interest rates, while a decrease indicates lower debt or improved interest terms.
- How does interest paid compare across companies?
- Standard across all companies; highly correlated with the company's total debt and credit rating.